Cargando…
Phenformin alone or combined with gefitinib inhibits bladder cancer via AMPK and EGFR pathways
BACKGROUND: In previous studies, we have shown that the combination of metformin and gefitinib inhibits the growth of bladder cancer cells. Here we examined whether the metformin analogue phenformin, either used alone or in combination with gefitinib, could inhibit growth of bladder cancer cells. ME...
Autores principales: | Huang, Yanjun, Zhou, Sichun, He, Caimei, Deng, Jun, Tao, Ting, Su, Qiongli, Darko, Kwame Oteng, Peng, Mei, Yang, Xiaoping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062982/ https://www.ncbi.nlm.nih.gov/pubmed/30053908 http://dx.doi.org/10.1186/s40880-018-0319-7 |
Ejemplares similares
-
Metformin and gefitinib cooperate to inhibit bladder cancer growth via both AMPK and EGFR pathways joining at Akt and Erk
por: Peng, Mei, et al.
Publicado: (2016) -
A novel synthetic derivative of quercetin, 8-trifluoromethyl-3,5,7,3′,4′-O-pentamethyl-quercetin, inhibits bladder cancer growth by targeting the AMPK/mTOR signaling pathway
por: Tao, Ting, et al.
Publicado: (2017) -
Dual Inhibition of Pirarubicin-Induced AKT and ERK Activations by Phenformin Sensitively Suppresses Bladder Cancer Growth
por: Peng, Mei, et al.
Publicado: (2019) -
Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer
por: Su, Qiongli, et al.
Publicado: (2018) -
Phenformin and ataxia‐telangiectasia mutated inhibitors synergistically co‐suppress liver cancer cell growth by damaging mitochondria
por: Wu, Tianyu, et al.
Publicado: (2021)